CCND3 and diffuse large B-cell lymphoma: For the biological process cell cycle, CCND3 mutation frequently occurs in DLBCL with multiple abnormal immunologic markers and is involved in uncontrolled cell cycle (12), the activation of which contributes to DLBCL progression (13).